238 related articles for article (PubMed ID: 9519495)
1. Acamprosate treatment in a long-term community-based alcohol rehabilitation programme.
Poldrugo F
Addiction; 1997 Nov; 92(11):1537-46. PubMed ID: 9519495
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of acamprosate for alcohol dependence in a family medicine setting in the United States: a randomized, double-blind, placebo-controlled study.
Berger L; Fisher M; Brondino M; Bohn M; Gwyther R; Longo L; Beier N; Ford A; Greco J; Garbutt JC
Alcohol Clin Exp Res; 2013 Apr; 37(4):668-74. PubMed ID: 23134193
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
Mason BJ; Goodman AM; Chabac S; Lehert P
J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
[TBL] [Abstract][Full Text] [Related]
4. Double-blind randomized multicentre trial of acamprosate in maintaining abstinence from alcohol.
Paille FM; Guelfi JD; Perkins AC; Royer RJ; Steru L; Parot P
Alcohol Alcohol; 1995 Mar; 30(2):239-47. PubMed ID: 7662044
[TBL] [Abstract][Full Text] [Related]
5. Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects.
Staner L; Boeijinga P; Danel T; Gendre I; Muzet M; Landron F; Luthringer R
Alcohol Clin Exp Res; 2006 Sep; 30(9):1492-9. PubMed ID: 16930211
[TBL] [Abstract][Full Text] [Related]
6. A pragmatic trial of acamprosate in the treatment of alcohol dependence in primary care.
Kiritzé-Topor P; Huas D; Rosenzweig C; Comte S; Paille F; Lehert P
Alcohol Alcohol; 2004; 39(6):520-7. PubMed ID: 15304381
[TBL] [Abstract][Full Text] [Related]
7. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
[TBL] [Abstract][Full Text] [Related]
8. Effect of community nurse follow-up when treating alcohol dependence with acamprosate.
Pelc I; Hanak C; Baert I; Houtain C; Lehert P; Landron F; Verbanck P
Alcohol Alcohol; 2005; 40(4):302-7. PubMed ID: 15870092
[TBL] [Abstract][Full Text] [Related]
9. The effects of combined acamprosate and integrative behaviour therapy in the outpatient treatment of alcohol dependence: a randomized controlled trial.
Wölwer W; Frommann N; Jänner M; Franke PE; Scherbaum N; Lieb B; Falkai P; Wobrock T; Kuhlmann T; Radermacher M; Maier W; Schütz C; Ohmann C; Burtscheidt W; Gaebel W
Drug Alcohol Depend; 2011 Nov; 118(2-3):417-22. PubMed ID: 21621929
[TBL] [Abstract][Full Text] [Related]
10. Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.
Namkoong K; Lee BO; Lee PG; Choi MJ; Lee E
Alcohol Alcohol; 2003; 38(2):135-41. PubMed ID: 12634260
[TBL] [Abstract][Full Text] [Related]
11. Why is disulfiram superior to acamprosate in the routine clinical setting? A retrospective long-term study in 353 alcohol-dependent patients.
Diehl A; Ulmer L; Mutschler J; Herre H; Krumm B; Croissant B; Mann K; Kiefer F
Alcohol Alcohol; 2010; 45(3):271-7. PubMed ID: 20348436
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of acamprosate for the treatment of alcohol dependence long after recovery from withdrawal syndrome: a randomized, double-blind, placebo-controlled study conducted in Japan (Sunrise Study).
Higuchi S;
J Clin Psychiatry; 2015 Feb; 76(2):181-8. PubMed ID: 25742205
[TBL] [Abstract][Full Text] [Related]
13. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
[TBL] [Abstract][Full Text] [Related]
14. Acamprosate efficacy in alcohol-dependent patients: summary of results from three pivotal trials.
Kranzler HR; Gage A
Am J Addict; 2008; 17(1):70-6. PubMed ID: 18214726
[TBL] [Abstract][Full Text] [Related]
15. Use of acamprosate and different kinds of psychosocial support in relapse prevention of alcoholism. Results from a non-blind, multicentre study.
Soyka M; Preuss U; Schuetz C
Drugs R D; 2002; 3(1):1-12. PubMed ID: 11881521
[TBL] [Abstract][Full Text] [Related]
16. Acamprosate and its efficacy in treating alcohol dependent adolescents.
Niederhofer H; Staffen W
Eur Child Adolesc Psychiatry; 2003 Jun; 12(3):144-8. PubMed ID: 12768462
[TBL] [Abstract][Full Text] [Related]
17. Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain.
Gual A; Lehert P
Alcohol Alcohol; 2001; 36(5):413-8. PubMed ID: 11524307
[TBL] [Abstract][Full Text] [Related]
18. Comparison of acamprosate and placebo in long-term treatment of alcohol dependence.
Whitworth AB; Fischer F; Lesch OM; Nimmerrichter A; Oberbauer H; Platz T; Potgieter A; Walter H; Fleischhacker WW
Lancet; 1996 May; 347(9013):1438-42. PubMed ID: 8676626
[TBL] [Abstract][Full Text] [Related]
19. Combined efficacy of acamprosate and disulfiram in the treatment of alcoholism: a controlled study.
Besson J; Aeby F; Kasas A; Lehert P; Potgieter A
Alcohol Clin Exp Res; 1998 May; 22(3):573-9. PubMed ID: 9622434
[TBL] [Abstract][Full Text] [Related]
20. Treatment of alcohol-dependent outpatients with acamprosate: a clinical review.
Mason BJ
J Clin Psychiatry; 2001; 62 Suppl 20():42-8. PubMed ID: 11584875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
